Most Dapagliflozin side effects are mild, dose-related and settle as treatment continues. The reactions that matter clinically are rare but need to be recognised quickly.
Key takeaways
- Common effects: urinary and genital infection, dehydration, hypotension.
- Avoid Dapagliflozin in severe renal impairment for glycaemic indication.
- Dose-related effects often resolve by stepping back one strength.
- Severe or persistent reactions warrant stopping and seeking review.
Frequency bands
| Frequency | Reactions | Action |
|---|---|---|
| Very common (>10%) | urinary and genital infection, dehydration | Usually self-limiting; supportive measures and reassurance. |
| Common (1–10%) | hypotension | Review dose and timing; consider dose reduction. |
| Uncommon (<1%) | hypersensitivity, marked laboratory changes | Stop and arrange clinical assessment. |
| Rare | serious organ-specific reactions | Stop immediately; urgent medical attention. |
Reducing the burden
Take Dapagliflozin exactly as directed: 10 mg once daily, any time of day. Splitting titration into smaller steps, dosing with food where the label allows, and hydrating well cover most tolerability problems seen in practice.
Dapagliflozin at a glance
| Attribute | Detail |
|---|---|
| Drug class | SGLT2 inhibitor |
| Common brand | Forxiga / Farxiga |
| Licensed use | type 2 diabetes, heart failure and chronic kidney disease |
| Available strengths | 5 mg, 10 mg |
| Dosage form | film-coated tablet |
| Typical onset | glucosuria within 24 hours |
| Duration / dosing interval | 24-hour dosing |
| Storage | below 30 °C |